Regulation of human mesenchymal stem cell differentiation by TREM-2

Human Immunology

Volumn 77, Issue 6, 2016, Pages 476-482

  Zhang, Wei Qiong ^a,b   Huang, Sheng Hui ^a,b   Huang, Xi ^c,e   Li, Jian Hua ^d   Ye, Pei ^a,b   Xu, Jinhuang ^b   Zheng, Pei Zhong ^b   Shen, Hui Yong ^a   Huang, Jian Rong ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Zengcheng District People's Hospital of Guangzhou   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e NONE   (China)

Author keywords

Human mesenchymal stem cells (h MSCs); Toll like receptors (TLRs); TREM 2 (triggering receptor expressed on myeloid cells 2)

Indexed keywords

LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; AUTACOID; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR; TREM2 PROTEIN, HUMAN;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOMODULATION; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; TISSUE REPAIR; CELL CULTURE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; WOUND HEALING;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; RECEPTORS, IMMUNOLOGIC; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTORS; WOUND HEALING;

EID: 85002787091     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.06.005     Document Type: Article

References (31)

1. [1] Pittenger, M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284:5411 (1999), 143–147.
2. [2] Nagaya, N., et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am. J. Physiol. Heart Circ. Physiol., 287(6), 2004 [H2670-6].
3. [3] Tatebe, M., et al. Differentiation of transplanted mesenchymal stem cells in a large osteochondral defect in rabbit. Cytotherapy 7:6 (2005), 520–530.
4. [4] Im, G.I., et al. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J. Bone. Joint Surg. Br. 83:2 (2001), 289–294.
5. [5] Bensaid, W., et al. De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng. 11:5–6 (2005), 814–824.
6. [6] Harris, C.T., Cooper, L.F., Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis. J. Biomed. Mater. Res. A 68:4 (2004), 747–755.
7. [7] Horwitz, E.M., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. U.S.A. 99:13 (2002), 8932–8937.
8. [8] Kawada, H., et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104:12 (2004), 3581–3587.
9. [9] Van Damme, A., et al. Bone marrow stromal cells as targets for gene therapy. Curr. Gene Ther. 2:2 (2002), 195–209.
10. [10] Uccelli, A., Moretta, L., Pistoia, V., Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8:9 (2008), 726–736.
11. [11] Ulevitch, R.J., Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4:7 (2004), 512–520.
12. [12] Bell, J.K., et al. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24:10 (2003), 528–533.
13. [13] Pevsner-Fischer, M., et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109:4 (2007), 1422–1432.
14. [14] Hwa, C.H., BAE, Y.C., Jung, J.S., Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24:12 (2006), 2744–2752.
15. [15] Bouchon, A., et al. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:8 (2001), 1111–1122.
16. [16] Daws, M.R., et al. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur. J. Immunol. 31:3 (2001), 783–791.
17. [17] Humphrey, M.B., et al. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J. Bone Miner. Res. 21:2 (2006), 237–245.
18. [18] Hamerman, J.A., et al. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6:6 (2005), 579–586.
19. [19] Ito, H., Hamerman, J.A., TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur. J. Immunol. 42:1 (2012), 176–185.
20. [20] Chu, C.L., et al. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRgamma. Eur. J. Immunol. 38:1 (2008), 166–173.
21. [21] Hamerman, J.A., Lanier, L.L., Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE, 2006(320), 2006, re1.
22. [22] Hamerman, J.A., et al. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177:4 (2006), 2051–2055.
23. [23] Blasius, A., et al. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. Blood 103:11 (2004), 4201–4206.
24. [24] Honda, K., Takaoka, A., Taniguchi, T., Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:3 (2006), 349–360.
25. [25] Selmani, Z., et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem cells 26:1 (2008), 212–222.
26. [26] Ford, J.W., McVicar, D.W., TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 21 (2009), 38–46.
27. [27] Park, M., et al. Triggering receptor expressed on myeloid cells 2 (TREM2) promotes adipogenesis and diet-induced obesity. Diabetes, 2014.
28. [28] Lee, N., et al. Role of human Toll-like receptors in naturally occurring influenza A infections. Influenza Other Respir. Viruses 7:5 (2013), 666–675.
29. [29] Reitz, C., Mayeux, R., TREM2 and neurodegenerative disease. N. Engl. J. Med. 369:16 (2013), 1564–1565.
30. [30] Gao, X., et al. Silencing of triggering receptor expressed on myeloid cells-2 enhances the inflammatory responses of alveolar macrophages to lipopolysaccharide. Mol. Med. Rep. 7:3 (2013), 921–926.
31. [31] Liu, D., et al. Impact of TREM-2 gene silencing on inflammatory response of endotoxin-induced acute lung injury in mice. Mol. Cell Biochem. 394:1–2 (2014), 155–161.